IOL Chemicals & Pharmaceuticals Downgraded to 'Sell' by MarketsMOJO Due to Poor Long-Term Growth and Negative Financial Results
IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been downgraded to a 'Sell' by MarketsMojo due to its poor long-term growth and negative financial results. Despite a low debt to equity ratio and fair valuation, the company's stock has underperformed the market and its profits have fallen. Investors should carefully consider all factors before investing.
IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has recently been downgraded to a 'Sell' by MarketsMOJO on August 22, 2024. This decision was based on the company's poor long-term growth, as its operating profit has only grown at an annual rate of 15.09% over the last 5 years.In addition, the company's recent financial results for the quarter ending June 24 have also been negative. Its net sales were at a low of Rs 502.38 crore, while its PBT LESS OI (profit before tax less other income) has fallen by -15.2% and its PAT (profit after tax) has fallen by -10.8%.
Despite being a smallcap company, IOL Chemicals & Pharmaceuticals has a low debt to equity ratio of 0.10 times. However, it is concerning that domestic mutual funds hold only 0.17% of the company. This could indicate that they are not comfortable with the company's current price or its business.
Moreover, the stock has underperformed the market in the last 1 year, generating a return of only 25.61% compared to the market's return of 37.99% (BSE 500). However, the technical trend for the stock has recently improved from Mildly Bearish to Mildly Bullish, with a return of 7.46% since August 20, 2024. Multiple factors such as MACD, Bollinger Band, KST, and OBV are currently bullish for the stock.
With a ROE (return on equity) of 8.3, the stock is currently fairly valued with a price to book value of 1.7. It is also trading at a discount compared to its average historical valuations. However, it is important to note that while the stock has generated a return of 25.61% in the past year, its profits have fallen by -21.4%.
In conclusion, while IOL Chemicals & Pharmaceuticals may seem like an attractive investment due to its low debt and fair valuation, its poor long-term growth and negative financial results may be a cause for concern. Investors should carefully consider all factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
